
preCharge News BUSINESS — Stockholm-listed shares of Swedish biotech firm Biotage jumped 56.1% by 10:25 a.m. in London, after private equity giant KKR made a $1.2 billion bid to take over the company.
In a statement on Tuesday, KKR said it had made a cash offer to Biotage shareholders of 145 Swedish krona ($15.24) per share. The offer values the company at around 11.6 billion krona, or $1.2 billion.
Biotage’s Board of Directors has recommended that shareholders accept the offer.